One-pot synthesis, anticancer, EGFR and caspases assays of novel fused [1,2,3]triazolo-pyrrolo[2,1-b]quinazolinones
-
Published:2025-01
Issue:
Volume:1320
Page:139570
-
ISSN:0022-2860
-
Container-title:Journal of Molecular Structure
-
language:en
-
Short-container-title:Journal of Molecular Structure
Author:
Udayasree Narahari,
Haridasyam Ramesh Babu,
Palabindela RambabuORCID,
Krishna Thupurani Murali,
Narsimha SirassuORCID
Reference49 articles.
1. Recent applications of 1,3-thiazole core structure in the identification of new lead compounds and drug discovery;Ayati;Eur. J. Med. Chem,2015
2. Novel quinoline-3-carboxamides (Part 2): design, optimization and synthesis of quinoline based scaffold as EGFR inhibitors with potent anticancer activity;Rasha;Bioorg. Chem.,2017
3. Review on epidermal growth factor receptor (EGFR) structure, signaling pathways, interactions, and recent updates of EGFR inhibitors;Sabbah;Curr. Top. Med. Chem.,2020
4. Epidermal growth factor receptor (EGFR) as a target in cancer therapy: understanding the role of receptor expression and other molecular determinants that could influence the response to anti-EGFR drugs;Ciardiello;Eur. J. Cancer,2003
5. FDA drug approval summary: erlotinib (Tarceva(R)) tablets;Cohen;Oncologist,2005